Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
Tanaka
K
K
Harvard Medical School, Dept of Surgery, Brigham and Women's Hospital, Boston, MA 02115.
Kupiec-Weglinski
J W
JW
Hancock
W W
WW
Stunkel
K
K
Diamantstein
T
T
Tilney
N L
NL
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000917:Antibody Formation; D003524:Cyclosporins / Q000627:therapeutic use*; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007074:Immunoglobulin G; D007165:Immunosuppression Therapy; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D014184:Transplantation, Homologous
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D007074:Immunoglobulin G; D015375:Receptors, Interleukin-2